Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study

• Главные авторы: Abdulaziz Saad Alshahrani (Автор), Danah Mohammad (Автор), Mohammad attieh Alzahrani (Автор), Neeraj Narula (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2023-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction: Several studies have shown increased incidence, recurrence, and severity of Clostridium difficile infection (CDI) over the last decade. Patients with inflammatory bowel disease (IBD) who develop CDI are more prone to morbidity and mortality than CDI in patients without IBD. This study...